Phytantriol-based cubosome formulation as an antimicrobial against Lipopolysaccharide-deficient gram-gegative bacteria
dc.contributor.author | Lai, XF | en_AU |
dc.contributor.author | Ding, Y | en_AU |
dc.contributor.author | Wu, CM | en_AU |
dc.contributor.author | Chen, X | en_AU |
dc.contributor.author | Jiang, JH | en_AU |
dc.contributor.author | Hsu, HY | en_AU |
dc.contributor.author | Wang, Y | en_AU |
dc.contributor.author | Le Brun, AP | en_AU |
dc.contributor.author | Song, JN | en_AU |
dc.contributor.author | Han, ML | en_AU |
dc.contributor.author | Li, J | en_AU |
dc.contributor.author | Shen, HH | en_AU |
dc.date.accessioned | 2024-12-12T22:00:50Z | en_AU |
dc.date.available | 2024-12-12T22:00:50Z | en_AU |
dc.date.issued | 2020-09-17 | en_AU |
dc.date.statistics | 2024-12-04 | en_AU |
dc.description.abstract | Treatment of multidrug-resistant (MDR) bacterial infections increasingly relies on last-line antibiotics, such as polymyxins, with the urgent need for discovery of new antimicrobials. Nanotechnology-based antimicrobials have gained significant importance to prevent the catastrophic emergence of MDR over the past decade. In this study, phytantriol-based nanoparticles, named cubosomes, were prepared and examined in vitro by minimum inhibitory concentration (MIC) and time-kill assays against Gram-negative bacteria: Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Phytantriol-based cubosomes were highly bactericidal against polymyxin-resistant, lipopolysaccharide (LPS)-deficient A. baumannii strains. Small-angle neutron scattering (SANS) was employed to understand the structural changes in biomimetic membranes that replicate the composition of these LPS-deficient strains upon treatment with cubosomes. Additionally, to further understand the membrane-cubosome interface, neutron reflectivity (NR) was used to investigate the interaction of cubosomes with model bacterial membranes on a solid support. These results reveal that cubosomes might be a new strategy for combating LPS-deficient Gram-negative pathogens. © 2020 American Chemical Society. | en_AU |
dc.description.sponsorship | The authors gratefully acknowledge the use of the facility and the assistance of Jisheng Ma at the Monash X-ray Platform (Monash University, Australia). They thank Heidi Yu and Hasini Wickremasinghe for their help in in vitro experiment, and Eric Hanssen from the Bio21 Advanced Microscopy Facility (The University of Melbourne, Australia) for his help in Cryo-TEM. The Australian Nuclear Science and Technology Organization (ANSTO) is gratefully acknowledged for providing the neutron research facilities (proposals P6945 and P8274). H.-H.S. is an Australian NHMRC Career Development Research Fellow (GNT1106798). This work was supported by the NHMRC project grant (APP1144652). | en_AU |
dc.format.medium | Print-Electronic | en_AU |
dc.identifier.citation | Lai, X., Ding, Y., Wu, C.-M., Chen, X., Jiang, J.-h., Hsu, H.-Y., Wang, Y., Le Brun, A. P., Song, J., Han, M.-L., Li, J., & Shen, H.-H. (2020). Phytantriol-based cubosome formulation as an antimicrobial against Lipopolysaccharide-deficient gram-gegative bacteria. ACS Applied Materials & Interfaces, 12(40), 44485-44498. doi:10.1021/acsami.0c13309 | en_AU |
dc.identifier.issn | 1944-8244 | en_AU |
dc.identifier.issn | 1944-8252 | en_AU |
dc.identifier.issue | 40 | en_AU |
dc.identifier.journaltitle | ACS Applied Materials & Interfaces | en_AU |
dc.identifier.pagination | 44485-44498 | en_AU |
dc.identifier.uri | https://doi.org/10.1021/acsami.0c13309 | en_AU |
dc.identifier.uri | https://apo.ansto.gov.au/handle/10238/15815 | en_AU |
dc.identifier.volume | 12 | en_AU |
dc.language | English | en_AU |
dc.language.iso | en | en_AU |
dc.publisher | American Chemical Society | en_AU |
dc.subject | Antimicrobial agents | en_AU |
dc.subject | Lipopolysaccharides | en_AU |
dc.subject | Bacteria | en_AU |
dc.subject | Lipids | en_AU |
dc.subject | Membranes | en_AU |
dc.subject | Neutron diffraction | en_AU |
dc.subject | Nanotechnology | en_AU |
dc.title | Phytantriol-based cubosome formulation as an antimicrobial against Lipopolysaccharide-deficient gram-gegative bacteria | en_AU |
dc.type | Journal Article | en_AU |